Capital International Inc. CA boosted its position in shares of Corteva, Inc. (NYSE:CTVA - Free Report) by 44.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 654,125 shares of the company's stock after purchasing an additional 201,285 shares during the period. Capital International Inc. CA owned approximately 0.10% of Corteva worth $37,259,000 at the end of the most recent quarter.
Other institutional investors and hedge funds also recently bought and sold shares of the company. Capital World Investors lifted its holdings in Corteva by 2,874.6% in the fourth quarter. Capital World Investors now owns 12,812,151 shares of the company's stock valued at $729,780,000 after acquiring an additional 12,381,436 shares during the last quarter. Independent Franchise Partners LLP grew its holdings in shares of Corteva by 51.5% during the 4th quarter. Independent Franchise Partners LLP now owns 16,496,508 shares of the company's stock worth $939,641,000 after purchasing an additional 5,604,838 shares during the period. Norges Bank purchased a new stake in Corteva in the 4th quarter valued at about $251,892,000. Raymond James Financial Inc. acquired a new stake in shares of Corteva during the fourth quarter valued at about $161,052,000. Finally, Franklin Resources Inc. raised its stake in shares of Corteva by 9.2% in the 4th quarter. Franklin Resources Inc. now owns 16,143,025 shares of the company's stock valued at $919,507,000 after acquiring an additional 1,354,418 shares during the period. 81.54% of the stock is currently owned by institutional investors and hedge funds.
Corteva Price Performance
CTVA stock traded up $0.64 on Thursday, reaching $61.71. 1,834,465 shares of the company's stock were exchanged, compared to its average volume of 3,307,839. The stock has a fifty day moving average of $60.82 and a 200-day moving average of $60.32. The firm has a market cap of $42.15 billion, a PE ratio of 47.83, a P/E/G ratio of 1.68 and a beta of 0.73. The company has a quick ratio of 0.93, a current ratio of 1.45 and a debt-to-equity ratio of 0.08. Corteva, Inc. has a twelve month low of $50.01 and a twelve month high of $66.24.
Corteva (NYSE:CTVA - Get Free Report) last posted its quarterly earnings results on Wednesday, February 5th. The company reported $0.32 earnings per share for the quarter, missing analysts' consensus estimates of $0.34 by ($0.02). Corteva had a return on equity of 7.19% and a net margin of 5.36%. As a group, equities analysts predict that Corteva, Inc. will post 2.96 EPS for the current fiscal year.
Corteva Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Monday, March 17th. Investors of record on Monday, March 3rd were issued a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.10%. The ex-dividend date of this dividend was Monday, March 3rd. Corteva's dividend payout ratio is currently 52.71%.
Insider Activity at Corteva
In other Corteva news, insider Brian Titus sold 26,560 shares of the firm's stock in a transaction dated Thursday, February 20th. The shares were sold at an average price of $63.74, for a total transaction of $1,692,934.40. Following the completion of the transaction, the insider now directly owns 11,347 shares in the company, valued at approximately $723,257.78. This trade represents a 70.07 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.14% of the stock is currently owned by company insiders.
Wall Street Analyst Weigh In
A number of research firms have commented on CTVA. UBS Group decreased their price target on Corteva from $74.00 to $73.00 and set a "buy" rating on the stock in a research note on Friday, January 10th. Citigroup lifted their price objective on shares of Corteva from $69.00 to $74.00 and gave the company a "buy" rating in a report on Wednesday, January 29th. Royal Bank of Canada increased their target price on shares of Corteva from $72.00 to $73.00 and gave the stock an "outperform" rating in a report on Friday, February 7th. Argus upgraded shares of Corteva from a "hold" rating to a "buy" rating and set a $69.00 price target for the company in a research note on Monday, March 31st. Finally, Wells Fargo & Company increased their price objective on Corteva from $67.00 to $73.00 and gave the company an "overweight" rating in a research note on Tuesday, January 28th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and fourteen have given a buy rating to the stock. According to MarketBeat, Corteva presently has an average rating of "Moderate Buy" and a consensus target price of $68.13.
Get Our Latest Report on Corteva
About Corteva
(
Free Report)
Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.
Read More

Before you consider Corteva, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Corteva wasn't on the list.
While Corteva currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.